Insider Trading activities of Complete Genomics Inc insiders.

Monthly summaries of insider trading activities (stock purchases, sales, and option exercises) reported by insiders of Complete Genomics Inc since 2005 are illustrated in Table 1 and Table 2. Table 1 shows the monthly insider trading data of Complete Genomics Inc since year 2005. Table 2 shows the detailed insider transactions of Complete Genomics Inc since 2005. The reporting company's ticker symbol is GNOM. The reporting company's CIK number is 1361103.
The total value of stock buying since 2005 is $19,672,143.
The total value of stock sales since 2005 is $11,889,303.
The total value of stock option exercises since 2005 is $176,602.


Table 1. Monthly summaries of insider stock purchases, sales, and option exercises for Complete Genomics Inc (GNOM).
Trading Period Insider Buying Insider Sales Option Exercises
year-month Shares Value Shares Value Shares Value
2012-11 0 $0 0 $0 4,166 $0
2012-07 0 $0 1,207,936 $3,305,023 0 $0
2012-03 0 $0 2,066,000 $6,229,122 0 $0
2011-12 200,000 $610,000 731,760 $2,242,350 0 $0
2011-11 0 $0 0 $0 3,332 $0
2011-10 0 $0 0 $0 80,000 $120,000
2011-09 0 $0 16,000 $112,808 16,000 $24,000
2011-08 10,000 $79,360 0 $0 0 $0
2011-05 10,623 $132,787 0 $0 0 $0
2011-02 0 $0 0 $0 21,735 $32,602
2010-11 2,094,444 $18,849,996 0 $0 0 $0

Table 2. Detailed insider stock purchases, sales, and option exercises of Complete Genomics Inc insiders (GNOM)
  Trade Date   Insider Name Trade Type     Shares       Price ($)   Value ($)
2012-11-30 Shuster Lewis (Director) Option Ex 833 .00 0
2012-11-30 Caskey C Thomas (Director) Option Ex 833 .00 0
2012-11-30 Wall Robert T (Director) Option Ex 833 .00 0
2012-11-30 Waite Charles P Jr (Director) Option Ex 1,667 .00 0
2012-07-13 Isaly Samuel D Sale 479,300 2.51 1,203,522
2012-07-12 Isaly Samuel D Sale 220,700 2.85 628,995
2012-07-11 Isaly Samuel D Sale 507,936 2.90 1,472,506
2012-03-16 Ovp Venture Partners Vi Lp (10% Owner) Sale 450,000 2.92 1,316,250
2012-03-16 Waite Charles P Jr (Director) Sale 450,000 2.92 1,316,250
2012-03-15 Ovp Venture Partners Vi Lp (10% Owner) Sale 165,059 2.89 477,185
2012-03-15 Waite Charles P Jr (Director) Sale 165,059 2.89 477,185
2012-03-14 Ovp Venture Partners Vi Lp (10% Owner) Sale 142,941 3.09 441,401
2012-03-14 Waite Charles P Jr (Director) Sale 142,941 3.09 441,401
2012-03-13 Ovp Venture Partners Vi Lp (10% Owner) Sale 275,000 3.20 879,725
2012-03-13 Waite Charles P Jr (Director) Sale 275,000 3.20 879,725
2011-12-14 Enterprise Partners Management Llc (10% Owner) Buy 100,000 3.05 305,000
2011-12-14 Senyei Andrew E (Director) Buy 100,000 3.05 305,000
2011-12-14 Waite Charles P Jr (Director) Sale 200,000 3.05 610,000
2011-12-09 Waite Charles P Jr (Director) Sale 42,800 3.00 128,442
2011-12-08 Waite Charles P Jr (Director) Sale 49,050 3.00 147,394
2011-12-07 Waite Charles P Jr (Director) Sale 110,840 3.09 342,716
2011-12-06 Waite Charles P Jr (Director) Sale 85,150 3.13 266,348
2011-11-30 Senyei Andrew E (Director) Option Ex 1,666 .00 0
2011-11-30 Waite Charles P Jr (Director) Option Ex 1,666 .00 0
2011-10-27 Drmanac Radoje T (Chief Scientific Officer) Option Ex 80,000 1.50 120,000
2011-09-21 Reid Clifford A (Chief Executive Officer) Sale 8,000 6.80 54,440
2011-09-21 Reid Clifford A (Chief Executive Officer) Option Ex 8,000 1.50 12,000
2011-09-20 Reid Clifford A (Chief Executive Officer) Sale 8,000 7.30 58,368
2011-09-20 Reid Clifford A (Chief Executive Officer) Option Ex 8,000 1.50 12,000
2011-08-08 Raffel Keith (SVP & Chief Commercial Officer) Buy 10,000 7.94 79,360
2011-05-26 Strand Advisors, Inc. (10% Owner) Buy 10,623 12.50 132,787
2011-02-09 Martin Bruce K (SVP of Product Development) Option Ex 21,735 1.50 32,602
2010-11-16 Essex Woodlands Health Ventures Fund Viii-b Lp (10% Owner) Buy 602,778 9.00 5,425,002
2010-11-16 Prospect Management Co. Iii, L.l.c. (10% Owner) Buy 333,333 9.00 2,999,997
2010-11-16 Senyei Andrew E (Director) Buy 111,111 9.00 999,999
2010-11-16 Barkas Alexander E (Director) Buy 333,333 9.00 2,999,997
2010-11-16 Enterprise Partners V L P (10% Owner) Buy 111,111 9.00 999,999
2010-11-16 Orbimed Advisors Llc (10% Owner) Buy 602,778 9.00 5,425,002

Insider trading activities including stock purchases, stock sales, and option exercises of GNOM listed in the above tables cannot be completely guaranteed as to their accuracy. For more insider trading information of Complete Genomics Inc (symbol GNOM, CIK number 1361103) see the Securities and Exchange Commission (SEC) website.